2012
DOI: 10.1007/s11524-012-9724-4
|View full text |Cite
|
Sign up to set email alerts
|

Adherence to Chronic Disease Medications among New York City Medicaid Participants

Abstract: Medication adherence is critical for cardiovascular disease prevention and control. Local health departments are well positioned to address adherence issues, however relevant baseline data and a mechanism for monitoring impact of interventions are lacking. We performed a retrospective analysis using New York State Medicaid claims from 2008 to 2009 to describe rates and predictors of adherence among New York City Medicaid participants with dyslipidemia, diabetes, or hypertension. Adherence was measured using th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
14
1
3

Year Published

2015
2015
2022
2022

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(18 citation statements)
references
References 17 publications
0
14
1
3
Order By: Relevance
“…3, 14 Female gender was associated with better adherence, which is inconsistent with a few others that have found the opposite relationship. 3, 17, 18, 31 However, this relationship did not become significant until SES indicators were entered into the model. In addition, being a racial/ethnic minority was significantly associated with being less adherent, as reported consistantly in the literature.…”
Section: Discussioncontrasting
confidence: 82%
See 2 more Smart Citations
“…3, 14 Female gender was associated with better adherence, which is inconsistent with a few others that have found the opposite relationship. 3, 17, 18, 31 However, this relationship did not become significant until SES indicators were entered into the model. In addition, being a racial/ethnic minority was significantly associated with being less adherent, as reported consistantly in the literature.…”
Section: Discussioncontrasting
confidence: 82%
“…1-3 As research has sought to determine what factors may underlie these disparities, socioeconomic status (SES) and medication adherence are particularly interesting. For example, macro indicators of SES (e.g., education, income) and micro indicators of SES (e.g., owning a home, having a checking account) have predicted CVD outcomes and have explained racial/ethnic disparities in CVD outcomes.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…African American women may be another group that is strongly impacted by comorbidities since these women are more likely to have sub-optimally managed comorbidities because of low medication adherence (Kyanko et al 2013 ;Bosworth et al 2008 ), which may decline further during breast cancer treatment (Calip et al 2013(Calip et al , 2014. African American breast cancer patients have more breast cancer recurrence/progression and worse all-cause, breast cancer specifi c and competing cause survival.…”
Section: Comorbidities Among Susceptible Populationsmentioning
confidence: 99%
“…5,6 Patient adherence to medication regimens is a key component of effective chronic disease management, yet medication adherence for these conditions tends to be low in the United States. [7][8][9][10] Failure of patients to adhere to medication regimens can lead to adverse health outcomes, such as worsening of chronic conditions, 11,12 preventable hospitalizations, 13,14 and death, [15][16][17] as well as potentially increasing health care costs. 13,18 -20 Several primary care practice models have been hypothesized to improve health outcomes for patients with chronic conditions-this includes the adoption of an electronic health record (EHR) as a means to assess a practice's patient population and proactively intervene (eg, care coordination for and management of high-risk populations).…”
mentioning
confidence: 99%